GA
MRNA icon

GraniteShares Advisors’s Moderna MRNA Stock Holding History

GraniteShares Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,831
Closed -$261K – 145
2022
Q2 		$261K Sell
1,831
-427
-19% -$61K 0.19% 119
2022
Q1 		$388K Buy
2,258
+325
+17% +$54.7K 0.21% 120
2021
Q4 		$490K Buy
+1,933
New +$565K 0.23% 119

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GraniteShares Advisors's MRNA Position: Q3 2022 in Review

GraniteShares Advisors sold out of Moderna (MRNA) in Q3 2022, closing a stake of 1,831 shares — an estimated $261K sold.

GraniteShares Advisors first reported a position in MRNA in Q4 2021 and held it in 3 quarters. The position peaked at $490K in Q4 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • GraniteShares Advisors reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • GraniteShares Advisors sold 1,831 Moderna shares in Q3 2022, an estimated $261K.
  • GraniteShares Advisors first reported a position in Moderna in Q4 2021 and held it in 3 quarters.
  • GraniteShares Advisors's Moderna position peaked at $490K in Q4 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on GraniteShares Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.